BRIEF published on 07/09/2024 at 15:05, 1 year 5 months ago Opkey Announces New AI-Powered Features Generative AI Machine Learning Data Privacy AI Test Automation No-Code ERP
BRIEF published on 07/09/2024 at 15:05, 1 year 5 months ago Opkey annonce de nouvelles fonctionnalités basées sur l'IA Apprentissage Automatique IA Générative Confidentialité Des Données Automatisation Des Tests D'IA ERP Sans Code
PRESS RELEASE published on 07/09/2024 at 15:00, 1 year 5 months ago Opkey Announces New AI-Powered Features Opkey introduces innovative AI features like Generative AI and Machine Learning to boost customer productivity in test automation. The platform ensures secure and efficient testing processes Innovation AI Productivity Test Automation Opkey
Published on 12/18/2025 at 00:55, 3 hours 16 minutes ago Molten Metals Corp. Announces Flow-Through Financing
Published on 12/18/2025 at 00:00, 4 hours 11 minutes ago Right Season Investments Announces Name Change to FutureGen Industries Corp.
Published on 12/17/2025 at 23:15, 4 hours 56 minutes ago Northern Superior Announces the Ratio for the Distribution of the Common Shares in the Capital of ONGold Resources Ltd.
Published on 12/17/2025 at 15:00, 13 hours 11 minutes ago BlackBerry Unveils Ground-Up Modernization of BlackBerry AtHoc Mobile Experience to Enable More Intelligent Operations
Published on 12/17/2025 at 14:00, 14 hours 11 minutes ago UniDoc Completes H3 Health Cube Installation in Italy
Published on 12/18/2025 at 01:10, 3 hours 1 minute ago Samsung To Unveil New AI-Connected Living Lineup at CES 2026
Published on 12/18/2025 at 00:50, 3 hours 21 minutes ago Historic production of graphene enhanced cement successfully completed
Published on 12/17/2025 at 22:05, 6 hours 6 minutes ago Abivax annonce l’acceptation de 22 abstracts sur obefazimod dans les MICI à l’ECCO 2026, dont une présentation orale sur des résultats précliniques antifibrotiques
Published on 12/17/2025 at 22:05, 6 hours 6 minutes ago Abivax Announces Acceptance of 22 Abstracts Evaluating Obefazimod in Inflammatory Bowel Disease at ECCO 2026, Featuring an Oral Presentation on Preclinical Anti-Fibrotic Findings
Published on 12/17/2025 at 21:22, 6 hours 49 minutes ago EQS-Adhoc: DATAGROUP SE: DATAGROUP SE Management Board plans dividend of EUR 0.04 per share
Published on 12/17/2025 at 20:39, 7 hours 32 minutes ago Aeroports de Paris SA | 2026 Airport charges in Paris
Published on 12/17/2025 at 20:39, 7 hours 32 minutes ago Aeroports de Paris SA | Tarifs des redevances aeroportuaires 2026 à Paris
Published on 12/17/2025 at 19:30, 8 hours 41 minutes ago Evolution de la composition du Conseil d’Administration
Published on 12/17/2025 at 18:00, 10 hours 11 minutes ago Outstanding Shares and Voting Rights Statement at 30 November 2025
